18FDG-PET/CT for treatment planning and follow-up

Treating Tumors that Move with Respiration

Volumn , Issue , 2007, Pages 55-61

  Osman, Medhat M ^a,b   Wall, Allison ^a   Miller, Matthew D ^a   Nguyen, Nghi ^b   Oliver, Dana A ^c   Bucholz, Richard D ^a   Walz, Bruce J ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891384911     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-69886-9_5     Document Type: Chapter

References (20)

1. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002; 53:89-112.
2. Wahl RL, Quint LE, Cieslak RD, et al. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993; 34:1190-1197.
3. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369-1379.
4. Akhurst T, Chisin R. Hybrid PET/CT machines: optimized PET machines for the new millennium? J Nucl Med 2000;41:961-963.
5. Osman M, Cohade C, Leal J, et al. Direct comparison of FDG-PET and PET-CT imaging in staging and restaging patients with lung cancer. Journal of Nuclear Medicine 2002; 43:151.P.
6. Lardinois D, Weder W, Hany TF, et al. Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507.
7. Keidar Z, Haim N, Guralnik L, et al. PET/CT using 18FFDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 2004; 45:1640-1646.
8. Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44:1200-1209.
9. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. Jama 2003; 290:3199-3206.
10. Bradley JD, Perez CA, Dehdashti F, et al. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med 2004;45 Suppl 1:96S-101.S.
11. Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002; 62:51-60.
12. Kiffer JD, Berlangieri SU, Scott AM, et al. The contribution of 18F-fl uoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998; 19:167-177.
13. Nestle U, Walter K, Schmidt S, et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999; 44:593-597.
14. Brianzoni E, Rossi G, Ancidei S, et al. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume. Eur J Nucl Med Mol Imaging 2005; 32:1392-1399.
15. Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57:853-863.
16. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006; 354:496-507.
17. Mac Manus MP, Hicks RJ, Matthews JP, et al. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 2005; 49:95-108.
18. Krak NC, Boellaard R, Hoekstra OS, et al. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging 2005; 32:294-301.
19. Miller M, Nguyen N, Oliver D, et al. Added Value of 18F FDG-PET/CT in CyberKnife Stereotactic Radiosurgery. 5th Annual CyberKnife Users' Meeting. Carlsbad, CA; 2006.
20. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006. J Nucl Med 2007; 48 Suppl 1:78S-88S.